FDA Panel Tables Recommendation On O-15 Imaging Agent, Okays F-18, N-13
This article was originally published in The Gray Sheet
Executive Summary
Additional information is needed to support FDA approval of water O-15 injection as an imaging agent to measure cerebral blood flow in patients with cerebral vascular disorders, FDA's Medical Imaging Drugs Advisory Committee concluded June 29.